Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Synthorx Inc. Appoints New CEO | Contract Pharma

What are you searching for?

Sign in
Promotions & Moves

Synthorx Inc. Appoints New CEO

The new addition is also currently a director of Relay Therapeutics as well as an advisor to the industry

By: Betsy Louda

, Contract Pharma

Synthorx Inc. has appointed Laura Shawver, Ph.D., as president, chief executive officer, and director. Dr. Shawver comes with many years of experience as an entrepreneur and drug developer, and has been involved with a number of clinical development programs including two FDA-approved therapies.

 

“Laura is an accomplished biotech leader, scientist, and drug developer, and we welcome the experience and enthusiasm that she brings to the Synthorx technology and team,” said Jay Lichter, Ph.D., president and chief executive officer of COI Pharmaceuticals and managing director of Avalon Ventures. 

 

Prior to joining Synthorx, Shawver was chief executive officer and director of Cleave Biosciences, entrepreneur-in-residence for 5AM Ventures, chief executive officer and director of Phenomix Corporation, and president of SUGEN Inc.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics